Tourniquet vs. Dual-flow Arthroscopy Sheath in Anterior Cruciate Ligament (ACL) Reconstruction

NCT ID: NCT06819696

Last Updated: 2025-11-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-12

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective randomized study comparing tourniquet use versus a dual-flow arthroscopy sheath in Anterior Cruciate Ligament (ACL) reconstruction surgery.

The ACL is largely responsible for knee stability and contributes to central pivot with the posterior cruciate ligament. ACL rupture is associated with a violent twisting motion of the knee, which is usually irreparable without surgical intervention.

ACL reconstruction via arthroscopy is the gold standard treatment for young, active patients with knee instability. Reconstruction is commonly performed using a thigh tourniquet to improve intraoperative visibility, reduce bleeding, and shorten procedure time. However, numerous studies associate tourniquet use with an increased risk of postoperative complications such as increased pain, muscle injury, postoperative bleeding, and deep vein thrombosis. Therefore, it seems relevant to conduct further investigations into the benefits of new methods to replace tourniquet. In this context, the dual-flow arthroscopy sheath could improve postoperative recovery after ACL reconstruction and could limit the risk of complications, thus improving ambulatory care for patients.

This study propose to compare two groups of patients undergoing ACL reconstruction: those operated on with a tourniquet versus those operated on using the dual-flow arthroscopy sheath.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Initial assessments will be conducted preoperatively. The follow-up examination will take place during the first 7 days following surgery and then at 21 days (D21), 45 days (D45), and 5 months postoperatively.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Cruciate Ligament Reconstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
The patient will be masked to the surgical procedure and will be unblinded upon completion of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dual-flow arthroscopy sheath

Patients will undergo ACL reconstruction using a dual-flow arthroscopy sheath.

Group Type EXPERIMENTAL

ACL reconstruction with a dual-flow arthroscopy sheath

Intervention Type PROCEDURE

ACL reconstruction will be performed by the surgeon without a tourniquet but using a dual-flow arthroscopy sheath.

Thigh tourniquet

Patients will undergo ACL reconstruction using a thigh tourniquet.

Group Type ACTIVE_COMPARATOR

ACL reconstruction with a thigh tourniquet

Intervention Type PROCEDURE

ACL reconstruction will be performed by the surgeon using a thight tourniquet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACL reconstruction with a dual-flow arthroscopy sheath

ACL reconstruction will be performed by the surgeon without a tourniquet but using a dual-flow arthroscopy sheath.

Intervention Type PROCEDURE

ACL reconstruction with a thigh tourniquet

ACL reconstruction will be performed by the surgeon using a thight tourniquet

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary ACL reconstruction
* Age 18 years or older
* Provided informed consent prior to study participation
* Affiliated to or beneficiary of a social security regimen

Exclusion Criteria

* Multi-ligamentous surgery
* Revision ACL surgery
* Presence of a meniscal and/or chondral lesion not allowing immediate weight-bearing postoperatively
* Bleeding disorder
* Pregnant, parturient or breastfeeding women
* Patient under legal guardianship
* Any other reason which, in the opinion of the investigator, could interfere with the evaluation of the objectives of the study objectives
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cédric SIEDLECKI, MD

Role: STUDY_DIRECTOR

Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer and Centre Hospitalier de Hyères

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier de Hyères

Hyères, Var, France

Site Status RECRUITING

Centre Hospitalier Intercommunal Toulon - La Seyne sur Mer

Toulon, Var, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Magali CESANA

Role: CONTACT

04 83 77 20 60 ext. +33

Steven LAUJAC

Role: CONTACT

04 94 14 60 67 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cédric SIEDLECKI, MD

Role: primary

04 94 14 50 00 ext. +33

Jean-Charles ESCUDIER, MD

Role: primary

04 94 14 50 00 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A01117-40

Identifier Type: OTHER

Identifier Source: secondary_id

2024-CHITS-007

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Tourniquet on UKA
NCT02465684 UNKNOWN NA
Fixed Versus Adjustable Loop in ACL Reconstruction
NCT03184922 ACTIVE_NOT_RECRUITING NA